petagene ltd Company Information
Company Number
10100283
Next Accounts
Dec 2025
Directors
Shareholders
daniel greenfield
romulus capital iii lp
View AllGroup Structure
View All
Industry
Business and domestic software development
Registered Address
31 high street, haverhill, CB9 8AD
Website
www.petagene.competagene ltd Estimated Valuation
Pomanda estimates the enterprise value of PETAGENE LTD at £1.1m based on a Turnover of £1.3m and 0.88x industry multiple (adjusted for size and gross margin).
petagene ltd Estimated Valuation
Pomanda estimates the enterprise value of PETAGENE LTD at £0 based on an EBITDA of £-216.4k and a 5.35x industry multiple (adjusted for size and gross margin).
petagene ltd Estimated Valuation
Pomanda estimates the enterprise value of PETAGENE LTD at £1.2m based on Net Assets of £514.5k and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Petagene Ltd Overview
Petagene Ltd is a live company located in haverhill, CB9 8AD with a Companies House number of 10100283. It operates in the business and domestic software development sector, SIC Code 62012. Founded in April 2016, it's largest shareholder is daniel greenfield with a 42.1% stake. Petagene Ltd is a young, small sized company, Pomanda has estimated its turnover at £1.3m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Petagene Ltd Health Check
Pomanda's financial health check has awarded Petagene Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs


3 Strong

3 Regular

5 Weak

Size
annual sales of £1.3m, make it smaller than the average company (£3.7m)
- Petagene Ltd
£3.7m - Industry AVG

Growth
3 year (CAGR) sales growth of 24%, show it is growing at a faster rate (10.5%)
- Petagene Ltd
10.5% - Industry AVG

Production
with a gross margin of 72.1%, this company has a comparable cost of product (72.1%)
- Petagene Ltd
72.1% - Industry AVG

Profitability
an operating margin of -17.2% make it less profitable than the average company (3.9%)
- Petagene Ltd
3.9% - Industry AVG

Employees
with 10 employees, this is below the industry average (33)
10 - Petagene Ltd
33 - Industry AVG

Pay Structure
on an average salary of £68.1k, the company has an equivalent pay structure (£68.1k)
- Petagene Ltd
£68.1k - Industry AVG

Efficiency
resulting in sales per employee of £129k, this is equally as efficient (£118.5k)
- Petagene Ltd
£118.5k - Industry AVG

Debtor Days
it gets paid by customers after 72 days, this is later than average (59 days)
- Petagene Ltd
59 days - Industry AVG

Creditor Days
its suppliers are paid after 12 days, this is quicker than average (39 days)
- Petagene Ltd
39 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Petagene Ltd
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 123 weeks, this is more cash available to meet short term requirements (18 weeks)
123 weeks - Petagene Ltd
18 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 27.5%, this is a lower level of debt than the average (59%)
27.5% - Petagene Ltd
59% - Industry AVG
PETAGENE LTD financials

Petagene Ltd's latest turnover from March 2024 is estimated at £1.3 million and the company has net assets of £514.5 thousand. According to their latest financial statements, Petagene Ltd has 10 employees and maintains cash reserves of £436.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
---|---|---|---|---|---|---|---|---|
Turnover | ||||||||
Other Income Or Grants | ||||||||
Cost Of Sales | ||||||||
Gross Profit | ||||||||
Admin Expenses | ||||||||
Operating Profit | ||||||||
Interest Payable | ||||||||
Interest Receivable | ||||||||
Pre-Tax Profit | ||||||||
Tax | ||||||||
Profit After Tax | ||||||||
Dividends Paid | ||||||||
Retained Profit | ||||||||
Employee Costs | ||||||||
Number Of Employees | 10 | 11 | 12 | 11 | 10 | 8 | 5 | 2 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | 7,719 | 11,092 | 14,092 | 20,883 | 19,065 | 17,006 | 3,114 | |
Intangible Assets | ||||||||
Investments & Other | 1 | 1 | 1 | 1,334 | 1,334 | |||
Debtors (Due After 1 year) | ||||||||
Total Fixed Assets | 7,719 | 11,093 | 14,093 | 20,884 | 20,399 | 18,340 | 3,114 | |
Stock & work in progress | ||||||||
Trade Debtors | 255,389 | 197,386 | 344,049 | 86,083 | 2,607 | |||
Group Debtors | 733 | 4,048 | 4,896 | 89,776 | 671,830 | 287,727 | ||
Misc Debtors | 9,760 | 134,493 | 264,271 | 95,326 | 56,549 | 724 | 1,744 | 912 |
Cash | 436,447 | 352,573 | 350,027 | 777,113 | 653,695 | 1,423,185 | 431,580 | 8,598 |
misc current assets | ||||||||
total current assets | 702,329 | 688,500 | 963,243 | 1,048,298 | 1,382,074 | 1,714,243 | 433,324 | 9,510 |
total assets | 710,048 | 699,593 | 977,336 | 1,069,182 | 1,402,473 | 1,732,583 | 436,438 | 9,510 |
Bank overdraft | 10,000 | 10,000 | 10,000 | 8,333 | ||||
Bank loan | ||||||||
Trade Creditors | 12,049 | 2,520 | 7,086 | 6,630 | 2,140 | 1,240 | 1,350 | |
Group/Directors Accounts | ||||||||
other short term finances | 70,000 | 80,000 | ||||||
hp & lease commitments | ||||||||
other current liabilities | 161,829 | 3,539,650 | 2,538,870 | 2,293,064 | 2,436,936 | 668,068 | 35,811 | 14,139 |
total current liabilities | 183,878 | 3,552,170 | 2,555,956 | 2,308,027 | 2,439,076 | 669,308 | 107,161 | 94,139 |
loans | 11,667 | 21,667 | 31,667 | 41,667 | 1,606,754 | 570,817 | ||
hp & lease commitments | ||||||||
Accruals and Deferred Income | ||||||||
other liabilities | 746,552 | 746,552 | ||||||
provisions | ||||||||
total long term liabilities | 11,667 | 21,667 | 778,219 | 788,219 | 1,606,754 | 570,817 | ||
total liabilities | 195,545 | 3,573,837 | 3,334,175 | 3,096,246 | 2,439,076 | 2,276,062 | 677,978 | 94,139 |
net assets | 514,503 | -2,874,244 | -2,356,839 | -2,027,064 | -1,036,603 | -543,479 | -241,540 | -84,629 |
total shareholders funds | 514,503 | -2,874,244 | -2,356,839 | -2,027,064 | -1,036,603 | -543,479 | -241,540 | -84,629 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | ||||||||
Depreciation | 6,038 | 9,276 | 9,680 | 8,828 | 6,289 | 1,871 | 443 | |
Amortisation | ||||||||
Tax | ||||||||
Stock | ||||||||
Debtors | -70,045 | -277,289 | 342,031 | -457,194 | 437,321 | 289,314 | 832 | 912 |
Creditors | 9,529 | -4,566 | 456 | 4,490 | 900 | -110 | 1,350 | |
Accruals and Deferred Income | -3,377,821 | 1,000,780 | 245,806 | -143,872 | 1,768,868 | 632,257 | 21,672 | 14,139 |
Deferred Taxes & Provisions | ||||||||
Cash flow from operations | ||||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | -1 | -1,333 | 1,334 | |||||
cash flow from investments | ||||||||
Financing Activities | ||||||||
Bank loans | ||||||||
Group/Directors Accounts | ||||||||
Other Short Term Loans | -70,000 | -10,000 | 80,000 | |||||
Long term loans | -10,000 | -10,000 | -10,000 | 41,667 | -1,606,754 | 1,035,937 | 570,817 | |
Hire Purchase and Lease Commitments | ||||||||
other long term liabilities | -746,552 | 746,552 | ||||||
share issue | ||||||||
interest | ||||||||
cash flow from financing | ||||||||
cash and cash equivalents | ||||||||
cash | 83,874 | 2,546 | -427,086 | 123,418 | -769,490 | 991,605 | 422,982 | 8,598 |
overdraft | 1,667 | 8,333 | ||||||
change in cash | 83,874 | 2,546 | -428,753 | 115,085 | -769,490 | 991,605 | 422,982 | 8,598 |
petagene ltd Credit Report and Business Information
Petagene Ltd Competitor Analysis

Perform a competitor analysis for petagene ltd by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other small companies, companies in CB9 area or any other competitors across 12 key performance metrics.
petagene ltd Ownership
PETAGENE LTD group structure
Petagene Ltd has no subsidiary companies.
Ultimate parent company
1 parent
PETAGENE LTD
10100283
petagene ltd directors
Petagene Ltd currently has 1 director, Dr Vaughan Wittorff serving since Jul 2024.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Vaughan Wittorff | England | 52 years | Jul 2024 | - | Director |
P&L
March 2024turnover
1.3m
+22%
operating profit
-222.4k
0%
gross margin
72.2%
+0.24%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
514.5k
-1.18%
total assets
710k
+0.01%
cash
436.4k
+0.24%
net assets
Total assets minus all liabilities
petagene ltd company details
company number
10100283
Type
Private limited with Share Capital
industry
62012 - Business and domestic software development
incorporation date
April 2016
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
HACKETT GRIFFEY LLP
auditor
-
address
31 high street, haverhill, CB9 8AD
Bank
-
Legal Advisor
-
petagene ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to petagene ltd.
petagene ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PETAGENE LTD. This can take several minutes, an email will notify you when this has completed.
petagene ltd Companies House Filings - See Documents
date | description | view/download |
---|